Abraxane Clinical Trials
5 recruitingDrug
Phase 24Phase 12
Showing 1–5 of 5 trials
Recruiting
Phase 2
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
Non-small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute318 enrolled5 locationsNCT06745882
Recruiting
Phase 2
Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.
The First Affiliated Hospital with Nanjing Medical University39 enrolled1 locationNCT07394387
Recruiting
Phase 2
Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy
Hepatic Artery InfusionLiver Metastasis of Breast Cancer
Zhejiang Cancer Hospital30 enrolled1 locationNCT07284836
Recruiting
Phase 1Phase 2
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Pancreatic Ductal AdenocarcinomaBiliary Tract Cancer (BTC)Gastric or Gastroesophageal Junction Adenocarcinoma
Phanes Therapeutics258 enrolled11 locationsNCT05482893
Recruiting
Phase 1
Combination of CAR-DC Vaccine and ICIs in Malignant Tumors
Solid Tumor, AdultLymphomaEphA2 Overexpression+4 more
Chinese PLA General Hospital10 enrolled1 locationNCT05631886